HarrisMartin's MDL Conference: JUUL and Capital One Data Breach Litigation Faculty
Attorney, author, teacher, pastor and expert storyteller, Mark Lanier is no stranger to the public platform. Since he founded The Lanier Law Firm in 1990, Mark has earned international recognition as one of the top trial attorneys in the United States, with firm offices in Houston, Oklahoma City, New York and Los Angeles supporting his work for clients across the country.
Neil D. Overholtz specializes in pharmaceutical litigation, and has successfully handled thousands of defective drug and medical device cases, including fen-phen, Rezulin, Baycol, Bextra/Celebrex, Vioxx, Medtronic Defibrillators, and Guidant Defibrillators.
Recently, Mr. Overholtz has the distinction of having been appointed as national counsel on the Plaintiffs’ Steering Committees for several federal products liability MDL’s (Mullti-District litigations), including the Trasylol MDL pending in federal court in West Palm Beach, Florida, before the Honorable Judge Middlebrooks, the Viagra MDL in the District Court in Minnesota, before the Honorable Judge Magnuson, as well as the Medtronic Sprint Fidelis Lead Wire MDL before United States District Court Judge Richard Kyle. Additionally, Mr. Overholtz has served as co-lead counsel in the In Re America Online, Inc Version 5.0 Software Litigation, MDL Docket No. 1341 (S.D. Fla), helping to negotiate a cash settlement for affected AOL members in excess of $15 Million as well as significant injunctive relief.
Mr. Overholtz has also recently served as co-chair of the Defective Medtronic Pacemakers and Defibrillators MDL discovery committee, and lead the firm’s efforts in national litigation, which resulted in a settlement of over $100 Million dollars. United States District Judge James Rosenbaum appointed Mr. Overholtz, to serve 25 of the Plaintiff’s Steering Committee Fee Committee. Mr. Overholtz also served a key role on the Guidant Defibrillators and Pacemakers MDL, which resulted in a settlement of over $200 Million dollars.
Richard “Rick” Meadow is the National Mass Tort Leader as well as the Director of Business Development for The Lanier Law Firm. His responsibilities include overseeing all the firm’s pharmaceutical mass tort litigation in addition to promoting, recruiting and maintaining associated outside relationships at a national level.
Mr. Meadow has represented the rights of individuals who have been injured by pharmaceuticals, medical devices, asbestos, medical malpractice, defective products, construction defects, lead poisoning, and motor vehicles, as well as the negligence of premises owners and municipalities for over 30 years. He further has extensive experience in the representation of large national insurance companies as an insurance defense attorney. This experience provides a 360-degree perspective of the practice of tort law in the United States. In addition, Mr. Meadow has served and continues to serve on the Plaintiffs’ Steering Committees for several national litigations.
Mr. Meadow has successfully tried over 25 cases to verdict. He was an integral part of the winning Lanier team that obtained record-setting plaintiffs’ verdicts in the Vioxx litigation. While at his former firm, he helped win two significant jury awards recognized by The National Law Journal among the nation’s largest verdicts in 2002 and 2003. He has settled claims for clients in the tens of millions. He has also argued appeals before the New York and New Jersey Appellate Divisions.
U.S. District Court Western District of Missouri, 1989
University of Iowa College of Law, Iowa City, Iowa, 1989
Honors: With Distinction
University of Iowa, Iowa City, Iowa, 1986
Honors: With Distinction
Beta Gamma SigmaPhi Eta Sigma
John A. Yanchunis, Morgan & Morgan, Tampa, FL